CAR T-cell therapy

Three years ago the retired NCCU Dean of Student Learning, 73, walked 60 miles to raise money for breast cancer. Now she's facing down an aggressive lymphoma.

NCCN released new Guidelines for Patients in it's Immunotherapy Side Effects series, with the publication of a book focused on CAR T-Cell therapy.

There's new hope for some lymphoma patients who've run out of options.

In January, DCI joined a select group of medical centers authorized to offer CAR T-cell therapy for patients with with certain types of relapsed or refractory non-Hodgkin’s lymphoma.